PRESS DIGEST- New York Times business news - May 12

Published 2016-05-12, 12:38 a/m
PRESS DIGEST- New York Times business news - May 12
AMGN
-
BHC
-
7201
-
7211
-

May 12 (Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.

- Several hospitals say nothing has changed since Valeant
VRX.TO vowed to offer hospitals breaks of as much as 30
percent on two of its expensive heart drugs - Nitropress and
Isuprel. Companies either curbed production or shut down completely
when the blaze struck Fort McMurray, Alberta, in an economic
blow to the region with production dropping by a million barrels
a day, roughly 40 percent of Alberta's output. Nissan 7201.T is in talks to acquire a major stake in
Mitsubishi Motors 7211.T to shield Mitsubishi from the impact
of a broadening fuel-economy cheating scandal. In the latest attempt to restore confidence in its
business, embattled Silicon Valley blood-testing company
Theranos is replacing its chief operating officer and expanding
its board, including the addition of a former senior Amgen
AMGN.O executive.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.